Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It

Mantle cell lymphoma (MCL) is a relatively rare

Specialty biopharmaceutical company Biovest

The FDA has made two significant changes to the dosage and safety information for the

Because science has only recently became familiar with mantle cell lymphoma, there aer not

Scientists have undertaken the first truly comprehensive analysis of

Results of a recently published Phase II study by Italian researchers indicate that

The U.S. Food and Drug Administration today has approved Imbruvica (ibrutinib) for the

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta,

The Leukemia and Lymphoma Society, the largest charity in the world dedicated to blood

Biovest International, makers of the personalized therapeutic lymphoma vaccine BiovaxID, have

Changing R-CHOP improved outcomes in patients with mantle cell lymphoma (MCL), according

At the recent ASH meeting in San Diego, researchers from Italy presented data supporting the use